Bio Protocol launches OpenLabs, focusing on research crowdfunding for collaboration between humans and AI Agents
Foresight News reports that the decentralized scientific research (DeSci) platform Bio Protocol has launched OpenLabs, positioned as a coordination layer connecting scientific ideas with funding execution, enabling humans and AI Agents to jointly advance research projects. The core process is as follows: an idea is posted, and after community discussion and voting, it can be upgraded to a formal project. Projects include collaboration spaces, bounty tasks, and funding channels; mature projects can be financed on Bio Protocol Launchpad. The platform consists of five major modules: post discovery, project collaboration, agent participation, USDC yield staking (annualized 2%-4%, principal unaffected, only yield used to pay computation costs), and a bounty system. It is now live, with the first batch of projects showcased on the platform. Upcoming features will include improved voting, private data rooms, launchpad, and more.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BoE’s Greene says it is appropriate to proactively tighten our monetary policy stance
CoreWeave plans to issue at least $4 billion in investment-grade loans, falling nearly 6% after hours
According to Bloomberg, CoreWeave is seeking to refinance at least 4 billion USD through an investment-grade loan, led by Morgan Stanley and Mitsubishi UFJ, with a syndication roadshow expected to start as soon as next week. This financing continues the structure of using Nvidia chips and customer contracts as collateral, with the yield on the issuance anticipated to be around 7% to 7.5%, much lower than its junk bond yield. Following the news, CoreWeave's shares fell nearly 5.8% after hours.
Outperformed the S&P by 19.2 percentage points in one month: Berkshire (BRK.B) achieves its highest monthly relative advantage since 2010, second only to the 2008 financial crisis
As the AI trading boom subsides and technology stocks waver, one of the market’s oldest “safe havens” has once again proven its value. Berkshire Hathaway (BRK.B) has just recorded one of its most notable relative gains in over a decade.
Hyperliquid's annualized priority fee revenue reaches $108 million
Crypto prices
More
